Patents by Inventor Matteo Righi

Matteo Righi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180346595
    Abstract: The present invention provides a cell which comprises a first chimeric antigen receptor (CAR) and a second CAR, wherein the first and second CARs bind different epitopes on the same ligand. The cell may be used in a method for treating a disease, such as cancer.
    Type: Application
    Filed: August 19, 2016
    Publication date: December 6, 2018
    Inventors: Martin Pulé, Shaun Cordoba, Matteo Righi, James Sillibourne
  • Publication number: 20180312570
    Abstract: The present invention provides a chimeric receptor which comprises: a ligand-binding exodomain; and an endodomain which comprises: (i) a cytokine receptor endodomain; and (ii) an intracellular T cell signalling domain.
    Type: Application
    Filed: October 21, 2016
    Publication date: November 1, 2018
    Applicant: AUTOLUS LIMITED
    Inventors: Martin Pulé, Shaun Cordoba, Matteo Righi
  • Publication number: 20180244797
    Abstract: The present invention provides a chimeric cytokine receptor (CCR) comprising: (i) an exodomain which binds to a ligand selected from a tumour secreted factor, a chemokine and a cell-surface antigen; and (ii) a cytokine receptor endodomain.
    Type: Application
    Filed: August 19, 2016
    Publication date: August 30, 2018
    Applicant: AUTOLUS LIMITED
    Inventors: Martin Pulé, Shaun Cordoba, Matteo Righi, James Sillibourne, Shimobi Onuoha, Simon Thomas
  • Patent number: D368008
    Type: Grant
    Filed: May 27, 1994
    Date of Patent: March 19, 1996
    Assignee: VICOM S.r.l.
    Inventors: Michele Golinelli, Matteo Righi